In vitro immunomodulatory properties of gemcitabine alone and in combination with interferon-alpha

In general, conventional chemotherapy is associated with significant toxicity leading to immunosuppression manifesting mainly in the lymphocyte depletion. This immunosuppression promotes tumor growth and elicits the tumor cell dissemination. However, chemotherapy can be immune stimulative especially...

Full description

Saved in:
Bibliographic Details
Main Authors: Fritz, Jasmin (Author) , Brecht, Ramona (Author) , Nachtigall, Ines (Author) , Werner, Jens (Author) , Bazhin, Alexandr V. (Author)
Other Authors: Karakhanova, Svetlana (Other)
Format: Article (Journal)
Language:English
Published: November 2015
In: Immunology letters
Year: 2015, Volume: 168, Issue: 1, Pages: 111-119
ISSN:1879-0542
DOI:10.1016/j.imlet.2015.09.017
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.imlet.2015.09.017
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0165247815300419
Get full text
Author Notes:Jasmin Fritz, Svetlana Karakhanova, Ramona Brecht, Ines Nachtigall, Jens Werner, Alexandr V. Bazhin
Description
Summary:In general, conventional chemotherapy is associated with significant toxicity leading to immunosuppression manifesting mainly in the lymphocyte depletion. This immunosuppression promotes tumor growth and elicits the tumor cell dissemination. However, chemotherapy can be immune stimulative especially in combination with an immunotherapy. In this work, we investigated in vitro effects of gemcitabine alone and in combination with interferon-alpha on splenocytes obtained from healthy and pancreatic carcinoma bearing mice. We showed that gemcitabine alone depletes the regulatory T cells in the splenocyte culture. Gemcitabine in combination with interferon-alpha demonstrated some immunomodulatory features, but these effects were interferon-alpha dependent. We concluded that combination of both drugs induces rather cumulative effects, supposing that these therapeutic could be applied together for a chemo-immunotherapy.
Item Description:Gesehen am 06.12.2018
Physical Description:Online Resource
ISSN:1879-0542
DOI:10.1016/j.imlet.2015.09.017